martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 3, 2026

Here's the Average Social Security Retired-Worker Benefit by Age (From 62 Through 99-Plus)

View original at nasdaq.com
Here's the Average Social Security Retired-Worker Benefit by Age (From 62 Through 99-Plus) Key Points Nearly a quarter-century of Gallup surveys show that Social Security income is relied upon by up to 90% of retirees to make ends meet…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • One easy trick could pay you as much as $23,760 more each year in Social Security benefits

    60% confidence
  • 26% of mothers were stay-at-home parents compared to just 7% of fathers

    60% confidence
  • Up to 90% of retirees rely on Social Security income to make ends meet

    60% confidence
  • Waiting until age 70 to initially collect benefits can increase their benefit by 24% to 32% above what they'd receive at full retirement age

    60% confidence
  • For every year a worker waits to initially collect their benefit, from age 62 until age 70, their payout can grow by up to 8%

    60% confidence
  • Spending more time out of the labor force has negatively impacted the earning potential for women, resulting in the observed drop-off in average retired-worker payouts from age 85 onward

    60% confidence
  • 80% to 90% of retirees rely on their Social Security payout to cover some portion of their expenses

    60% confidence
  • Claiming at age 62 can permanently reduce a worker's monthly payout by 25% to 30%, depending on their birth year

    60% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Here's the Average Social Security Retired-Worker Benefit by Age (From 62 Through 99-Plus) — Source | Via News | es.VIA.NEWS